Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pediatric Brain Tumor × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Hyperinsulinism 1 Breast Neoplasms 1

Interventions

poly ICLC 1 dapagliflozin 1 Topotecan 1 Cyclophosphamide 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05521984 2025-12-08

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine

Phase 1 Recruiting

Other solid neoplasm

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡